X-Linked adrenoleukodystrophy: Clinical and laboratory findings in 15 Brazilian patients

Genetics and Molecular Biology

Volumn 23, Issue 2, 2000, Pages 261-264

  Vargas, Carmen R ^a   Coelho, Daniella De M ^a   Barschak, Alethéa G ^a   De Souza, Carolina F M ^a   Puga, Ana C S ^a   Schwartz, Ida V D ^a   Jardim, Laura ^a,b   Giugliani, Roberto ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LORENZO OIL; MEVINOLIN; VERY LONG CHAIN FATTY ACID;

ADOLESCENT; ADRENAL CORTEX INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CLINICAL STUDY; DEMYELINATING DISEASE; DIET THERAPY; DISORDERS OF PEROXISOMAL FUNCTIONS; FATTY ACID BLOOD LEVEL; GAS CHROMATOGRAPHY; GENETIC COUNSELING; HUMAN; LABORATORY DIAGNOSIS; MALE; MUSCLE WEAKNESS; PRENATAL DIAGNOSIS; SCHOOL CHILD; X CHROMOSOME LINKAGE;

EID: 0033898869     PISSN: 14154757     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1415-47572000000200002     Document Type: Article

References (16)

1. Koike, R., Tsuji, S., Ohno, T., Suzuki, Y., Orri, T. and Miyatake, T. (1991). Physiological significance of fatty acid elongation system in adrenoleukodystrophy. J. Neurol. Sci. 103: 188-196.
2. Korenke, G.C., Hunneman, D.H., Kohler, J., Stöcker, S., Landmark, K. and Hanefeld, F. (1995). Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters. Eur. J. Pediatr. 154: 64-70.
3. Moser, H.W. (1993). Lorenzo's oil. Lancet. 341: 544.
4. Moser, H.W. (1995). Adrenoleukodystrophy: natural history, treatment and outcome. J. Inherited Metab. Dis. 18: 435-447.
5. Moser, H.W. and Moser, A.B. (1991). Measurement of saturated very long chain fatty acid in plasma. In: Techniques in Diagnostics Human Biochemical Genetics (Hommes, F.A., ed.). Wiley-Liss, New York, 177-191.
6. Moser, H.W., Bergin, A., Naidu, S. and Ledenson, P.W. (1991). Adrenoleukodystrophy. Endocrinol. Metab. Clin. North Am. 20: 297-318.
7. Moser, H.W., Moser, A.B., Smith, K.D., Bergin, A., Borel, J., Shankroff, J., Stine, O.C., Merette, C., Ott, J., Krivit, W. and Shapiro, E. (1992). Adrenoleukodystrophy: phenotypic variability and implications for therapy. J. Inherited Metab. Dis. 15: 645-664.
8. Moser, H.W., Kok, F., Neumann, S., Borel, J., Bergin, A., Mostafa, S.D., Panoscha, R., Davoli, C., Shankroff, J. and Smith, K. (1994). Adrenoleukodystrophy update: genetic and effect of Lorenzo's oil therapy in asymptomatic patients. Int. Pediatr. 9: 196-204.
9. Ruiz, M., Pampols, T. and Girós, M. (1996). Glycerol trioleate/glycerol trierucate therapy in X-linked adrenoleukodystrophy: saturated and insaturated fatty acids in blood cells. Implications for the follow-up. J. Inherited Metab. Dis. 19: 188-192.
10. Singh, I., Khan, M., Key, L. and Pai, S. (1998a). Lovastatin for X-linked adrenoleukodystrophy. N. Engl. J. Med. 339: 702-703.
11. Singh, I., Pahan, K. and Khan, M. (1998b). Lovastatin and sodium phenylacetate normalise the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy. FEBS Lett. 426: 342-346.
12. Wanders, R.J.A., Van Roermund, C.W., Van Wijland, M.J., Schutgens, R.B.H., Schram, A.W., Tager, J.M., Bosch, H.V. and Schalkwijk, C. (1988). X-linked adrenoleukodystrophy: identification of the primary defect at the level of a deficient peroxisomal very long chain fatty acyl-Coa synthetase using a newly developed method for the isolation of peroxisomes from skin fibroblasts. J. Inherited Metab. Dis. 11: 173-177.
13. Wanders, R.J.A., Van Roermund, C.W.T., Lageweg, W., Jakobs, B.S., Schutgens, R.B.H., Nijenheis, A.A. and Tager, J.M. (1992). X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect. J. Inherited Metab. Dis. 15: 634-644.
14. Wanders, R.J.A., Barth, P.G., Schutgens, R.B.H. and Tager, J.M. (1994). Clinical and biochemical characteristics of peroxisomal disorders: an update. Eur. J. Pediatr. 153 (Suppl. 1): S44-S48.
15. Wanders, R.J.A., Schutgens, R.B.H. and Barth, P.G. (1995). Peroxisomal disorders: a review. J. Neuropathol. Exp. Neurol. 17: 726-739.
16. Wanders, R.J.A., Schutgens, R.B.H. and Barth, P.G. (1996). Peroxisomal disorders. In: Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases (Blau, N., Duran, M. and Blaskovics, M.E., eds.). Chapman & Hall Medical, London, pp. 359-376.